Pregnant Women In Clinical Trials: Investigators Should Justify Exclusion, NIH Official Says
Executive Summary
Enrollment-boosting strategy backed by industry rep at Duke-Margolis meeting as FDA official suggests having sponsors develop study plans for pregnant and lactating women with ‘elements of’ the requirement for pediatric studies.